Further, we propose α-MSH-induced CRE-driven reporter gene activity be the preferred high-throughput screen to discover potential safe and effective anti-MC4R signaling therapeutics targeting obesity. Here, STAMBP is linked to obesity due to melanocortin 4 receptor deficiency.